Corporate News     15-May-20
Alembic Pharmaceuticals receives USFDA approval for Doxycycline Hyclate Tablets
Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Doxycycline Hyclate Tablets USP 100mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Vibra-Tabs, 100mg of Pfizer, Inc. Doxycycline Hyclate Tablets USP 100mg should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

Doxycycline Hyclate Tablets 100mg have an estimated market size of US$ 53 million for twelve months ending December 2019 according to IQVIA.

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 2.41% in the September 2023 quarter
 ( Results - Announcements 07-Nov-23   15:08 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 20-Jul-23   14:30 )
  Alembic Pharmaceuticals to declare Quarterly Result
 ( Corporate News - 18-Apr-24   16:14 )
  Alembic Pharma rises on USFDA nod for breast cancer drug
 ( Hot Pursuit - 01-Apr-24   13:52 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 08-Jun-23   14:30 )
  Alembic Pharmaceuticals receives USFDA approval (final & tentative) for 11 products
 ( Corporate News - 03-Jul-24   15:42 )
  Alembic Pharma gets USFDA nod for Icatibant injection
 ( Hot Pursuit - 17-Jun-24   14:03 )
  Alembic Pharmaceuticals appoints Head - Technical Operations (Sterile & Oncology)
 ( Corporate News - 16-Sep-24   17:45 )
  Alembic Pharmaceuticals receives USFDA approval for Glycopyrrolate Injection
 ( Corporate News - 01-Nov-22   11:41 )
  Alembic Pharma gets USFDA nod for breast cancer drug
 ( Hot Pursuit - 26-Dec-22   09:44 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 01-Nov-22   12:10 )
Other Stories
  ITD Cementation India wins order of Rs 1,937 cr
  03-Oct-24   10:35
  NIIT Learning Systems allots 1,666 equity shares under ESOP
  03-Oct-24   10:30
  Ashoka Metcast to discuss results
  03-Oct-24   10:29
  Emerald Finance to declare Quarterly Result
  03-Oct-24   10:29
  Rhetan TMT schedules board meeting
  03-Oct-24   10:29
  Shrenik to table results
  03-Oct-24   10:29
  Universal Arts to declare Quarterly Result
  03-Oct-24   10:28
  Three M Paper Boards to conduct board meeting
  03-Oct-24   10:28
  Arkade Developers to declare Quarterly Result
  03-Oct-24   10:28
  Worth Investment & Trading Company announces board meeting date
  03-Oct-24   10:28
Back Top